Dr. Grosso will develop and implement the company’s expanding clinical trial agenda. Tevogen’s cell therapy research pipeline focuses on virology, neurology, and oncology. Tevogen is reported as the ...
DANBURY, Conn.--(BUSINESS WIRE)--Perosphere Technologies (Perosphere Technologies Inc.), a private medical technologies company focused on developing next-generation coagulation diagnostics, today ...
Dr. Nicholas Grosso: Extending the maximum stay time at ASCs to 48 hours would make outpatient surgery a safer option for a wider variety of patients, like those who may be at-risk for surgical ...
In this episode, Dr. Nicholas Grosso and Dr. Louis Levitt, Co-Founders of The Centers for Advanced Orthopaedics and MedVanta, discuss their physician-led MSO and how it is transforming musculoskeletal ...
Columbia, Md.-based The Center for Advanced Orthopaedics’ Nicholas Grosso, MD, urged consumers to seek out private practices in a column for U.S. News & World Report. 1. Although the quantity of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results